18h
AB Science will hold a web conference on Wednesday, October 14, 2026, from 6:00 p.m. to 7:30 p.m.
PRESS RELEASE AB SCIENCE WILL HOLD A WEB CONFERENCE ON WEDNESDAY, OCTOBER 14, FROM 6:00 P.M. TO 7:30 P.M. AB Science SA ...
In April 2026, AB Science announced that it had reached a final agreement with its financial creditors. This agreement provides for a two-year deferral of the repayment of the State-Guaranteed Loans ...
AB Science has received a binding offer for a Clinical Trial Funding Insurance policy from Medical & Commercial International Ltd. (MCI), Lloyd's Syndicate 1902, for its Phase III clinical trial ...
AB SCIENCE PROVIDES AN UPDATE ON ITS DEVELOPMENT PLAN AND FINANCIAL CALENDAR FOLLOWING A SPONSOR GOOD CLINICAL PRACTICE INSPECTION Confirmation of the relevance of having, among the first decisions of ...
AB Science S.A. considered that its development plan will need to be adapted as follows: Step 2: Resumption of the phase 1 study in acute myeloid leukemia (compound AB8939) within the framework of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results